Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome

Basit Öğe Kaydı
dc.contributor.authorAl Khatib, Shadi
dc.contributor.authorKeleş, Sevgi
dc.contributor.authorGarcia-Lioret, Maria
dc.contributor.authorAydıner, Elif Kara Koç
dc.contributor.authorReisli, İsmail
dc.contributor.authorArtaç, Hasibe
dc.contributor.authorÇamcıoğlu, Yıldız
dc.date.accessioned2020-03-26T17:38:10Z
dc.date.available2020-03-26T17:38:10Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractBackground: The hyper IgE syndrome (HIES) is characterized by abscesses, eczema, recurrent infections, skeletal and connective tissue abnormalities, elevated serum IgE, and diminished inflammatory responses. It exists as autosomal-dominant and autosomal-recessive forms that manifest common and distinguishing clinical features. A majority of those with autosomal-dominant HIES have heterozygous mutations in signal transducer and activator of transcription (STAT)-3 and impaired T(H)17 differentiation. Objective: To elucidate mechanisms underlying different forms of HIES. Methods: A cohort of 25 Turkish children diagnosed with HIES were examined for STAT3 mutations by DNA sequencing. Activation of STAT3 by IL-6 and IL-21 and STAT1 by IFN-alpha was assessed by intracellular staining with anti-phospho (p)STAT3 and -pSTAT1 antibodies. T(H)17 and T(H)1 cell differentiation was assessed by measuring the production of IL-17 and IFN-gamma, respectively. Results: Six subjects had STAT3 mutations affecting the DNA binding, Src homology 2, and transactivation domains, including 3 novel ones. Mutation-positive but not mutation-negative subjects with HIES exhibited reduced phosphorylation of STAT3 in response to cytokine stimulation, whereas pSTAT1 activation was unaffected. Both patient groups exhibited impaired TH17 responses, but whereas STAT3 mutations abrogated early steps in TH17 differentiation, the defects in patients with HIES with normal STAT3 affected more distal steps. Conclusion: In this cohort of Turkish children with HIES, a majority had normal STAT3, implicating other targets in disease pathogenesis. Impaired TH17 responses were evident irrespective of the STAT3 mutation status, indicating that different genetic forms of HIES share a common functional outcome. (J Allergy Clin Immunol 2009;124:342-8.)en_US
dc.description.sponsorshipNational Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01AI065617]en_US
dc.description.sponsorshipSupported by National Institutes of Health grant 5R01AI065617 (T.C.).en_US
dc.identifier.doi10.1016/j.jaci.2009.05.004en_US
dc.identifier.endpage348en_US
dc.identifier.issn0091-6749en_US
dc.identifier.issn1097-6825en_US
dc.identifier.issue2en_US
dc.identifier.pmid19577286en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage342en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.jaci.2009.05.004
dc.identifier.urihttps://hdl.handle.net/20.500.12395/23394
dc.identifier.volume124en_US
dc.identifier.wosWOS:000268860400023en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMOSBY-ELSEVIERen_US
dc.relation.ispartofJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectHyper IgE syndromeen_US
dc.subjectSTAT3en_US
dc.subjectT(H)17en_US
dc.subjectIL-6en_US
dc.subjectIL-21en_US
dc.subjectROR gamma ten_US
dc.titleDefects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu